SPL 2.22% 9.2¢ starpharma holdings limited

2011 2014 2015

  1. 752 Posts.
    Have a look at the past 3 CR and commentary around completion of P3 for prevention of BV ... anyone else see this... ??

    9 Dec 2015 - 32 M raised
    ...The funds will also support the licensing, approvals and launches of the VivaGel® BV symptomatic relief product and the completion of the Phase 3 trials of VivaGel® for prevention of recurrent bacterial vaginosis (BV) which are well advanced.

    20 Sept 2014 -$13M raised
    The funds raised will be used to support the completion of the Phase 3 trials of VivaGel® for prevention of recurrent bacterial vaginosis (BV), regulatory and commercialisation activities of VivaGel® for Symptomatic Relief of BV...

    16 Nov 2011 - $32M raised
    Funds raised will be used to accelerate and complete both VivaGel® Bacterial Vaginosis Phase 3 Programs (Treatment, and Prevention of Recurrence) supporting an NDA filing and commercial licence...
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $37.93M
Open High Low Value Volume
9.2¢ 9.2¢ 9.2¢ $184 1.999K

Buyers (Bids)

No. Vol. Price($)
1 106501 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 64997 1
View Market Depth
Last trade - 10.08am 16/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.